Ziopharm Oncology reported $216K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Amgen AMGN:US $ 31989M 112M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
AstraZeneca AZN:LN 387M 59M
Baxter International BAX:US $ 683M 0M
Biogen BIIB:US $ 0.1M 0M
Bioline Rx BLRX:US $ 20.87M 0.38M
Bristol Myers Squibb BMY:US $ 292M 0M
Corcept Therapeutics CORT:US $ 0.13M 0M
Curis CRIS:US $ 0.92M 0M
Eleven Biotherapeutics EBIO:US $ 0.2M 0.01M
GlaxoSmithKline GSK:LN 1347M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Novartis NOVN:VX SF 901M 12M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sangamo Biosciences SGMO:US $ 1.46M 0M
Verastem VSTM:US $ 0.02M 0M
YTE INCY:US $ 0.22M 0M
Ziopharm Oncology ZIOP:US $ 0.22M 0M